Therapeutic monoclonal antibodies (mAbs) have demonstrated promising outcomes in diverse clinical indications, including but not limited to graft rejection, cancer, and autoimmune diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results